🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and assertions of rapid British shipping. Vendors market the substance there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting products of uncertain source.

Some professionals stated the popularity for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Platform Reaction and Material Removal

Based on the social media company, the service has removed problematic content and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at home.

Within moments of joining one group, a seller shared contact information, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.

Item Details and Costs

Inside these groups, messages display dark colored packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When questioned how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram stated it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject patients to potentially significant health risks”.